Dow Down 1.40% Nasdaq Down 1.59%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
5.91 Down 0.04(0.67%) 4:15PM EDT
Prev Close:5.95
Open:5.93
Bid:5.50 x 1000
Ask:N/A
1y Target Est:9.50
Beta:1.76
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.66 - 5.97
52wk Range:1.77 - 7.63
Volume:1,206,089
Avg Vol (3m):2,401,220
Market Cap:465.12M
P/E (ttm):N/A
EPS (ttm):-0.97
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
FOLDDown 0.67%465.12M
SHPGDown 0.23%50.52B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):361.88
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.94
Quarterly EPS Est (Sep-14) :-0.21
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback